3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
26
Neoplasm Metastasis
5
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Polycystic Ovary Syndrome
2
Infertility
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Neoplasms, Male
2
Advanced Breast Cancer
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexual Dysfunctions, Psychological
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Leiomyoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
HR+/HER2- Breast Cancer
1
HER2 Negative Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Ductal
1
Breast Neoplasm Female
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Anovulation
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
pembrolizumab
3
Doxorubicin
3
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
selinexor
1
ribociclib
1
peposertib
1
pazopanib
1
palbociclib
1
mirdametinib
1
liposomal doxorubicin
1
abemaciclib
1
X-Rays
1
Surgical Procedures, Operative
1
Radiotherapy
1
Radiation
1
Proton Therapy
1
Neoadjuvant Therapy
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Everolimus
1
Biopsy
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liposarcoma
×
Letrozole
×
30 days
×
Clear all
No trials found.